My favourite sentence from the report? The financial foundation this
gives Neuren to target repeating the success on a larger scale with NNZ-2591 across multiple indications
should not be underestimated.”
..."should not be underestimated".
I just changed my sentiment to 'buy"
- Forums
- ASX - By Stock
- Ann: 2024 results - A$166m comprehensive income for shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.63%
!
$14.06

My favourite sentence from the report? The financial foundation...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.06 |
Change
0.750(5.63%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$13.50 | $14.09 | $12.96 | $4.638M | 339.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 179 | $14.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 590 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14 | 14.040 |
6 | 342 | 14.030 |
8 | 867 | 14.020 |
8 | 1148 | 14.010 |
9 | 9861 | 14.000 |
Price($) | Vol. | No. |
---|---|---|
14.050 | 37 | 1 |
14.060 | 533 | 5 |
14.070 | 1456 | 6 |
14.080 | 1371 | 4 |
14.090 | 1379 | 6 |
Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online